home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

417 rows where in_cev_map = 0, surface_class = "A_surface" and tier = "Tier 1.5" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: pdb_count_total, aptamer_count_pubmed

has_structure 2

  • 0 230
  • 1 187

has_known_aptamer 2

  • 0 355
  • 1 62

has_cryoEM 2

  • 0 305
  • 1 112

tier 1

  • Tier 1.5 · 417 ✖

surface_class 1

  • A_surface · 417 ✖

in_cev_map 1

  • - · 417 ✖

has_activation_state_pdb_pair 1

  • 0 417
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
O95255 ABCC6 ATP-binding cassette sub-family C member 6 Tier 1.5 0.809 1 A_surface 4 80.94 0 0     0 0   0 Pseudoxanthoma elasticum 0.864631668818611
P21439 ABCB4 Phosphatidylcholine translocator ABCB4 Tier 1.5 0.806 1 A_surface 4 83.25 1 0     0 0   0 progressive familial intrahepatic cholestasis type 3 0.851728159166962
P31785 IL2RG Cytokine receptor common subunit gamma Tier 1.5 0.804 1 A_surface 14 75.5 1 0     1 2 30800133, 33869115 0 gamma chain deficiency 0.8469997000418428
Q9UM01 SLC7A7 Y+L amino acid transporter 1 Tier 1.5 0.804 1 A_surface 5 83.81 1 0     0 0   0 lysinuric protein intolerance 0.8450026270275782
P08100 RHO Rhodopsin Tier 1.5 0.804 1 A_surface 4 88.75 1 0     1 45 41963275, 41924874, 41636061, 40808302, 40642289, 40330320, 40045571, 39863313, 39788632, 38070612, 37191882, 36705086, 36696850, 36095194, 36049339, 35622174, 34709779, 34471566, 32696702, 32479610, 32319623, 32119944, 31737572, 31588238, 31535128, 29570714, 29281176, 28648779, 27893356, 25645980, 23757206, 23701883, 25033804, 22689339, 22302221, 22121695, 19766091, 19389625, 16419035, 12123800, 8743323, 7678562, 19188685, 18230760 0 retinitis pigmentosa 0.8481942240861982
P48029 SLC6A8 Sodium- and chloride-dependent creatine transporter 1 Tier 1.5 0.804 1 A_surface 6 84.62 1 0     0 0   0 creatine transporter deficiency 0.847268393806457
Q9UQD0 SCN8A Sodium channel protein type 8 subunit alpha Tier 1.5 0.803 1 A_surface 4 68.38 1 0     0 0   0 developmental and epileptic encephalopathy, 13 0.8437707419548253
O95342 ABCB11 Bile salt export pump Tier 1.5 0.801 1 A_surface 8 83.12 1 0     1 1 36313979 0 progressive familial intrahepatic cholestasis type 2 0.8372060401943777
P78508 KCNJ10 ATP-sensitive inward rectifier potassium channel 10 Tier 1.5 0.801 1 A_surface 4 82.44 1 0     0 0   0 EAST syndrome 0.8357483559927158
P30968 GNRHR Gonadotropin-releasing hormone receptor Tier 1.5 0.799 1 A_surface 1 84.19 0 0     0 0   0 hypogonadotropic hypogonadism 0.83100005285263
Q16281 CNGA3 Cyclic nucleotide-gated channel alpha-3 Tier 1.5 0.799 1 A_surface 10 74.44 1 0     0 0   0 achromatopsia 0.8315799021867489
P10912 GHR Growth hormone receptor Tier 1.5 0.799 1 A_surface 9 58.69 0 0     1 5 38811951, 38477735, 31603904 0 Laron syndrome 0.8304020079647765
P13866 SLC5A1 Sodium/glucose cotransporter 1 Tier 1.5 0.797 1 A_surface 4 84.38 1 0     0 0   0 glucose-galactose malabsorption 0.8220991027793896
Q04844 CHRNE Acetylcholine receptor subunit epsilon Tier 1.5 0.797 1 A_surface 13 80.69 1 0     0 0   0 Congenital myasthenic syndromes 0.8223287249629152
P23942 PRPH2 Peripherin-2 Tier 1.5 0.796 1 A_surface 1 87.0 1 0     0 0   0 retinitis pigmentosa 0.8194208847382956
Q9BZV2 SLC19A3 Thiamine transporter 2 Tier 1.5 0.796 1 A_surface 19 81.56 1 0     0 0   0 biotin-responsive basal ganglia disease 0.8189646480334981
Q5JUK3 KCNT1 Potassium channel subfamily T member 1 Tier 1.5 0.795 1 A_surface 6 73.88 1 0     0 0   0 developmental and epileptic encephalopathy, 14 0.8165232785825526
Q9NQW8 CNGB3 Cyclic nucleotide-gated channel beta-3 Tier 1.5 0.791 1 A_surface 9 68.12 1 0     0 0   0 achromatopsia 0.8033348000666748
Q01718 MC2R Adrenocorticotropic hormone receptor Tier 1.5 0.79 1 A_surface 2 85.38 1 0     0 0   0 familial glucocorticoid deficiency 0.8001007686411645
O43525 KCNQ3 Potassium voltage-gated channel subfamily KQT member 3 Tier 1.5 0.789 1 A_surface 1 56.72 0 0     0 0   0 Benign familial neonatal seizures 0.7961763561533409
P37023 ACVRL1 Activin receptor type-1-like Tier 1.5 0.789 1 A_surface 7 82.0 0 0     0 0   0 telangiectasia, hereditary hemorrhagic, type 2 0.7951167515831324
P16410 CTLA4 Cytotoxic T-lymphocyte protein 4 Tier 1.5 0.787 1 A_surface 22 80.12 0 0     1 26 41907643, 40972397, 40870970, 40811947, 40536609, 39417693, 38473398, 38158454, 36966395, 36831533, 36603108, 36015348, 33970170, 32929022, 32840510, 32280743, 32024070, 31405808, 28918052, 28082399, 26030229, 25565435, 24892807, 23460536, 23460531, 14612549 0 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency 0.7906408646569979
Q13698 CACNA1S Voltage-dependent L-type calcium channel subunit alpha-1S Tier 1.5 0.786 1 A_surface 2 71.81 0 0     0 0   0 hypokalemic periodic paralysis, type 1 0.7869997029542154
O95622 ADCY5 Adenylate cyclase type 5 Tier 1.5 0.785 1 A_surface 2 73.19 1 0     0 0   0 dyskinesia with orofacial involvement, autosomal dominant 0.7830401650561951
Q96MS0 ROBO3 Roundabout homolog 3 Tier 1.5 0.784 1 A_surface 3 63.69 0 0     1 2 32369590 0 horizontal gaze palsy with progressive scoliosis 0.7813306356858872
P51168 SCNN1B Epithelial sodium channel subunit beta Tier 1.5 0.783 1 A_surface 5 82.44 1 0     0 0   0 bronchiectasis with or without elevated sweat chloride 1 0.775668400727201
O43497 CACNA1G Voltage-dependent T-type calcium channel subunit alpha-1G Tier 1.5 0.783 1 A_surface 2 58.22 1 0     0 0   0 Spinocerebellar ataxia type 42 0.7770459773037601
P43004 SLC1A2 Excitatory amino acid transporter 2 Tier 1.5 0.783 1 A_surface 7 77.75 1 0     0 0   0 developmental and epileptic encephalopathy, 41 0.7772658651722512
Q8TDI8 TMC1 Transmembrane channel-like protein 1 Tier 1.5 0.781 1 A_surface 1 76.88 0 0     0 0   0 autosomal recessive nonsyndromic hearing loss 7 0.7694318181814068
P48547 KCNC1 Voltage-gated potassium channel KCNC1 Tier 1.5 0.78 1 A_surface 10 78.56 1 0     0 0   0 Progressive myoclonic epilepsy 0.7675090944252294
Q13255 GRM1 Metabotropic glutamate receptor 1 Tier 1.5 0.779 1 A_surface 4 70.94 1 0     0 0   0 autosomal recessive spinocerebellar ataxia 13 0.7631507286490296
P51654 GPC3 Glypican-3 Tier 1.5 0.779 1 A_surface 4 75.06 1 0     1 65 42083729, 41790019, 41653459, 41045695, 40825648, 40722645, 39998646, 39874791, 39608318, 39427046, 38910291, 38787447, 38621313, 38368644, 37665421, 36903516, 36457288, 36317566, 36072763, 35788872, 35699181, 35477501, 35051745, 34974867, 34306031, 33254049, 33080969, 32356075, 30347351, 30122918, 29675356, 29605994, 29277631, 27601357, 28263753 0 Simpson-Golabi-Behmel syndrome type 1 0.762708583613362
Q9NUN7 ACER3 Alkaline ceramidase 3 Tier 1.5 0.777 1 A_surface 2 93.19 0 0     0 0   0 alkaline ceramidase 3 deficiency 0.7575827142824458
P20023 CR2 Complement receptor type 2 Tier 1.5 0.776 1 A_surface 9 74.94 1 0     1 1 33235290 0 immunodeficiency, common variable, 7 0.7543125403898414
P40126 DCT L-dopachrome tautomerase Tier 1.5 0.774 1 A_surface 1 89.12 0 0     1 1 27245069 0 oculocutaneous albinism type 8 0.7468868816172217
Q86YC3 NRROS Transforming growth factor beta activator LRRC33 Tier 1.5 0.773 1 A_surface 1 83.31 1 0     0 0   0 seizures, early-onset, with neurodegeneration and brain calcifications 0.744630610851649
Q9Y6J6 KCNE2 Potassium voltage-gated channel subfamily E member 2 Tier 1.5 0.772 1 A_surface 1 78.25 0 0     0 0   0 Romano-Ward syndrome 0.739531738338193
O75899 GABBR2 Gamma-aminobutyric acid type B receptor subunit 2 Tier 1.5 0.771 1 A_surface 26 77.75 1 0     0 0   0 developmental and epileptic encephalopathy, 59 0.7356789732167734
O43914 TYROBP TYRO protein tyrosine kinase-binding protein Tier 1.5 0.77 1 A_surface 5 64.62 0 0     0 0   0 Nasu-Hakola disease 0.7323368313860329
Q16572 SLC18A3 Vesicular acetylcholine transporter Tier 1.5 0.77 1 A_surface 7 76.19 1 0     0 0   0 Congenital myasthenic syndromes 0.7324174860789537
P08887 IL6R Interleukin-6 receptor subunit alpha Tier 1.5 0.768 1 A_surface 10 77.88 1 0     1 18 40853309, 38152968, 37034659, 36579647, 35890412, 33590853, 33340765, 32515246, 29211023, 28929152, 26552813, 26383776, 24481022, 24440854, 23235494, 22503683, 22258147, 22094809 0 rheumatoid arthritis 0.7269057706798291
P30542 ADORA1 Adenosine receptor A1 Tier 1.5 0.767 1 A_surface 5 92.44 1 0     0 0   0 asthma 0.7232344154541454
Q00975 CACNA1B Voltage-dependent N-type calcium channel subunit alpha-1B Tier 1.5 0.767 1 A_surface 7 59.91 1 0     1 2 31118475, 25782368 0 Seizure 0.7217241968702018
Q9Y5Y9 SCN10A Sodium channel protein type 10 subunit alpha Tier 1.5 0.764 1 A_surface 8 67.31 1 0     0 0   0 atrial fibrillation 0.7126293968222049
Q13705 ACVR2B Activin receptor type-2B Tier 1.5 0.763 1 A_surface 9 83.31 1 0     0 0   0 Heterotaxia 0.7109733260300651
Q2M385 MPEG1 Macrophage-expressed gene 1 protein Tier 1.5 0.761 1 A_surface 5 82.75 1 0     0 0   0 immunodeficiency 77 0.7043238859467001
Q9NPI9 KCNJ16 Inward rectifier potassium channel 16 Tier 1.5 0.761 1 A_surface 4 78.12 1 0     0 0   0 hypokalemic tubulopathy and deafness 0.7018965238443493
Q9H2X9 SLC12A5 Solute carrier family 12 member 5 Tier 1.5 0.76 1 A_surface 2 78.44 1 0     0 0   0 genetic developmental and epileptic encephalopathy 0.6993945840545625
P48023 FASLG Tumor necrosis factor ligand superfamily member 6 Tier 1.5 0.76 1 A_surface 3 80.19 0 0     1 1 16581027 0 autoimmune lymphoproliferative syndrome type 1 0.6984292519156657
Q8IWU4 SLC30A8 Proton-coupled zinc antiporter SLC30A8 Tier 1.5 0.759 1 A_surface 3 82.12 1 0     0 0   0 type 2 diabetes mellitus 0.6974093822415375

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 434.985ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target